Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Nucleoside analog ARC targets Mcl-1 to induce apoptosis in leukemia cells.

× No keyword cloud information.

8 in total

1. Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing Bak activation and Bax translocation.

Authors: Shuang Chen; Yun Dai; Hisashi Harada; Paul Dent; Steven Grant
Journal: Cancer Res Date: 2007-01-15 Impact factor: 12.701

2. An inhibitor of Bcl-2 family proteins induces regression of solid tumours.

Authors: Tilman Oltersdorf; Steven W Elmore; Alexander R Shoemaker; Robert C Armstrong; David J Augeri; Barbara A Belli; Milan Bruncko; Thomas L Deckwerth; Jurgen Dinges; Philip J Hajduk; Mary K Joseph; Shinichi Kitada; Stanley J Korsmeyer; Aaron R Kunzer; Anthony Letai; Chi Li; Michael J Mitten; David G Nettesheim; ShiChung Ng; Paul M Nimmer; Jacqueline M O'Connor; Anatol Oleksijew; Andrew M Petros; John C Reed; Wang Shen; Stephen K Tahir; Craig B Thompson; Kevin J Tomaselli; Baole Wang; Michael D Wendt; Haichao Zhang; Stephen W Fesik; Saul H Rosenberg
Journal: Nature Date: 2005-05-15 Impact factor: 49.962

3. Differential sensitivity of human colon cancer cell lines to the nucleoside analogs ARC and DRB.

Authors: Uppoor G Bhat; Andrei L Gartel
Journal: Int J Cancer Date: 2008-03-15 Impact factor: 7.396

4. Novel anticancer compounds induce apoptosis in melanoma cells.

Authors: Uppoor G Bhat; Patricia A Zipfel; Douglas S Tyler; Andrei L Gartel
Journal: Cell Cycle Date: 2008-06-30 Impact factor: 4.534

5. Transcriptional and translational control of Mcl-1 during apoptosis.

Authors: Daniel Iglesias-Serret; Maria Piqué; Joan Gil; Gabriel Pons; José M López
Journal: Arch Biochem Biophys Date: 2003-09-15 Impact factor: 4.013

6. A novel transcriptional inhibitor induces apoptosis in tumor cells and exhibits antiangiogenic activity.

Authors: Senthil K Radhakrishnan; Andrei L Gartel
Journal: Cancer Res Date: 2006-03-15 Impact factor: 12.701

7. Proapoptotic compound ARC targets Akt and N-myc in neuroblastoma cells.

Authors: S K Radhakrishnan; M Halasi; U G Bhat; R T Kurmasheva; P J Houghton; A L Gartel
Journal: Oncogene Date: 2007-09-03 Impact factor: 9.867

8. ARC (NSC 188491) has identical activity to Sangivamycin (NSC 65346) including inhibition of both P-TEFb and PKC.

Authors: Luke H Stockwin; Sherry X Yu; Howard Stotler; Melinda G Hollingshead; Dianne L Newton
Journal: BMC Cancer Date: 2009-02-20 Impact factor: 4.430

8 in total

5 in total

1. ARC synergizes with ABT-737 to induce apoptosis in human cancer cells.

Authors: Uppoor G Bhat; Bulbul Pandit; Andrei L Gartel
Journal: Mol Cancer Ther Date: 2010-06-01 Impact factor: 6.261

Review 2. Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases.

Authors: Lars Petter Jordheim; David Durantel; Fabien Zoulim; Charles Dumontet
Journal: Nat Rev Drug Discov Date: 2013-06 Impact factor: 84.694

3. Understanding sensitivity to BH3 mimetics: ABT-737 as a case study to foresee the complexities of personalized medicine.

Authors: Vasileios A Stamelos; Charles W Redman; Alan Richardson
Journal: J Mol Signal Date: 2012-08-16

4. Transcription inhibition as a therapeutic target for cancer.

Authors: Christine M Stellrecht; Lisa S Chen
Journal: Cancers (Basel) Date: 2011-11-23 Impact factor: 6.639

5. Circumvention of Mcl-1-dependent drug resistance by simultaneous Chk1 and MEK1/2 inhibition in human multiple myeloma cells.

Authors: Xin-Yan Pei; Yun Dai; Jessica Felthousen; Shuang Chen; Yukie Takabatake; Liang Zhou; Leena E Youssefian; Michael W Sanderson; Wesley W Bodie; Lora B Kramer; Robert Z Orlowski; Steven Grant
Journal: PLoS One Date: 2014-03-04 Impact factor: 3.240

5 in total